These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 28389391)
21. Real-life experience in the treatment of solar urticaria: retrospective cohort study. Snast I; Lapidoth M; Uvaidov V; Enk CD; Mazor S; Hodak E; Levi A Clin Exp Dermatol; 2019 Jul; 44(5):e164-e170. PubMed ID: 30828851 [TBL] [Abstract][Full Text] [Related]
22. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema. Lang DM Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165 [No Abstract] [Full Text] [Related]
23. Successful treatment of symptomatic dermographism in an adolescent with omalizumab. Kaya Erdogan H; Ağaoğlu E; Acer E; Batan T; Saracoglu ZN Dermatol Ther; 2020 Nov; 33(6):e14304. PubMed ID: 32926517 [No Abstract] [Full Text] [Related]
24. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy. Ensina LF; Cusato-Ensina AP; Camelo-Nunes IC; Solé D J Investig Allergol Clin Immunol; 2017; 27(5):326-327. PubMed ID: 29057743 [No Abstract] [Full Text] [Related]
25. Omalizumab as a treatment option for antihistamine-refractory aquagenic urticaria. Kaur S; Jabbal IS; Bhasin AK BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35850790 [TBL] [Abstract][Full Text] [Related]
26. Case of postural urticaria in a 14-year-old girl. Gabrielli S; Le M; Netchiporouk E; Ben-Shoshan M BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34711626 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of omalizumab in severe solar urticaria. de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538 [No Abstract] [Full Text] [Related]
28. Urticaria control test might misevaluate disease control in particular patients treated with omalizumab. Türk M; Yılmaz İ Ann Allergy Asthma Immunol; 2019 Mar; 122(3):342-343. PubMed ID: 30529015 [No Abstract] [Full Text] [Related]
29. Use of omalizumab in the treatment of chronic urticaria. Cordeiro Moreira AS; Rosmaninho Lopes de Soares E Silva MI; Pereira Guilherme MA; da Silva Ferreira JA; Fonseca Moreira da Silva JP Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):242-246. PubMed ID: 27852430 [TBL] [Abstract][Full Text] [Related]
30. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience. Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A; Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719 [TBL] [Abstract][Full Text] [Related]
31. Use of Antihistamines During Omalizumab Therapy in Chronic Urticaria in the Routine Clinical Practice. A 48-Patient Observational Trial. Menéndez-Sánchez M; Pérez-Fernández E; López-Estebaranz JL; Gómez-de la Fuente E Actas Dermosifiliogr; 2024 Jun; 115(6):636-638. PubMed ID: 38382744 [No Abstract] [Full Text] [Related]
32. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. Kaplan A; Ferrer M; Bernstein JA; Antonova E; Trzaskoma B; Raimundo K; Rosén K; Omachi TA; Khalil S; Zazzali JL J Allergy Clin Immunol; 2016 Feb; 137(2):474-81. PubMed ID: 26483177 [TBL] [Abstract][Full Text] [Related]